Elmwood Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$306K Sell
12,723
-303
-2% -$7.93K 0.08% 159
2026
Q1
$366K Sell
13,026
-84
-0.6% -$2.24K 0.1% 138
2025
Q4
$326K Buy
13,110
+1,754
+15% +$44.2K 0.1% 137
2025
Q3
$289K Buy
11,356
+1,075
+10% +$26.5K 0.1% 124
2025
Q2
$249K Sell
10,281
-45
-0.4% -$1.05K 0.1% 120
2025
Q1
$262K Hold
10,326
0.11% 119
2024
Q4
$274K Sell
10,326
-50
-0.5% -$1.36K 0.11% 117
2024
Q3
$300K Sell
10,376
-37
-0.4% -$1.08K 0.12% 116
2024
Q2
$291K Sell
10,413
-1,200
-10% -$33K 0.13% 108
2024
Q1
$322K Buy
11,613
+1,004
+9% +$27.9K 0.14% 106
2023
Q4
$305K Sell
10,609
-9,164
-46% -$277K 0.21% 91
2023
Q3
$656K Sell
19,773
-10
-0.1% -$354 0.32% 87
2023
Q2
$726K Sell
19,783
-85
-0.4% -$3.31K 0.34% 83
2023
Q1
$811K Buy
19,868
+30
+0.2% +$1.3K 0.38% 79
2022
Q4
$1.02M Buy
19,838
+191
+1% +$9.16K 0.51% 72
2022
Q3
$860K Buy
19,647
+400
+2% +$19.4K 0.43% 73
2022
Q2
$1.01M Hold
19,247
0.57% 66
2022
Q1
$996K Hold
19,247
0.51% 69
2021
Q4
$1.14M Buy
+19,247
New +$954K 0.54% 64
2021
Q2
$739K Hold
18,872
0.39% 74
2021
Q1
$684K Buy
+18,872
New +$670K 0.42% 72
2020
Q3
$614K Hold
19,786
0.5% 66
2020
Q2
$614K Buy
19,786
+1,143
+6% +$38.8K 0.5% 66
2020
Q1
$628K Sell
18,643
-898
-5% -$30.6K 0.6% 60
2019
Q4
$726K Hold
19,541
0.63% 63
2019
Q3
$666K Hold
19,541
0.67% 56
2019
Q2
$803K Hold
19,541
0.71% 56
2019
Q1
$787K Hold
19,541
0.73% 54
2018
Q4
$809K Buy
19,541
+1,054
+6% +$43.8K 0.78% 49
2018
Q3
$773K Hold
18,487
0.64% 60
2018
Q2
$636K Sell
18,487
-156
-0.8% -$5.33K 0.58% 63
2018
Q1
$628K Buy
+18,643
New +$641K 0.6% 60

Other funds holding PFE

Elmwood Wealth Management's PFE Position: Q2 2026 in Review

Elmwood Wealth Management reduced its Pfizer (PFE) stake by 2.3% in Q2 2026, selling an estimated $7.93K and leaving 12,723 shares worth $306K. The position accounts for 0.08% of the portfolio, ranked #159.

Elmwood Wealth Management first reported a position in PFE in Q1 2018 and has held it in 32 quarters since. The position peaked at $1.14M in Q4 2021. 557 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Elmwood Wealth Management held 12,723 shares of Pfizer worth $306K as of Q2 2026.
  • Elmwood Wealth Management sold 303 Pfizer shares in Q2 2026, an estimated $7.93K.
  • Pfizer made up 0.08% of Elmwood Wealth Management's portfolio in Q2 2026, its #159 holding.
  • Elmwood Wealth Management first reported a position in Pfizer in Q1 2018 and has held it in 32 quarters since.
  • Elmwood Wealth Management's Pfizer position peaked at $1.14M in Q4 2021.
  • 557 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Elmwood Wealth Management's 13F filing for Q2 2026, filed 8 Jul 2026.